HAMLET TO4 B — HAMLET Pharma AB Balance Sheet
0.000.00%
- SEK261.96m
- SEK222.34m
Annual balance sheet for HAMLET Pharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 15.5 | 10.6 | 13.2 | 7.47 | 39.6 |
| Net Total Receivables | 0.422 | 0.485 | 0.754 | 0.496 | 0.847 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16.2 | 11.2 | 14.5 | 12.7 | 41.7 |
| Net Property, Plant And Equipment | 0.396 | 0.081 | 0.045 | 0.009 | 0 |
| Total Assets | 16.6 | 11.3 | 14.6 | 12.7 | 41.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.77 | 3.25 | 4.08 | 9.99 | 3.72 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.77 | 3.25 | 4.08 | 9.99 | 3.72 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 14.8 | 8.03 | 10.5 | 2.75 | 38 |
| Total Liabilities & Shareholders' Equity | 16.6 | 11.3 | 14.6 | 12.7 | 41.7 |
| Total Common Shares Outstanding |